Sign In
Free Newsletter
Senseonics gets Medicare payment rate decision, has Q3 loss
Health care providers will be able to bill Medicare directly for inserting a Germantown company's implantable blood sugar monitor into patients under new federal policies for 2020.
Senseonics gains 2 large US insurers for implantable monitor
Senseonics Holdings Inc., the Germantown company that developed the only long-term implantable system for monitoring blood sugar, has had its system approved by more insurance carriers.
Senseonics begins US 180-day study of implantable monitor
The Germantown company that developed the only long-term implantable system for monitoring blood sugar has begun a clinical study to study its system when implanted for twice as long as is now allowed in the United States.
Senseonics aims to boost insurance coverage by publishing data
A Germantown company that developed the only long-term implantable system for monitoring blood sugar has published data it hopes will convince more insurers to cover the system for patients with diabetes.
Senseonics sees Q2 revenue increase, offers stocks, notes
A Germantown company that makes an implantable glucose monitor saw increased revenue in the second quarter, according to unaudited numbers it announced. Senseonics Holdings Inc. said in a news release […]
Senseonics gets approval to give patients dosing information
A Germantown company that makes an implantable glucose monitor has received FDA approval to use the system to make dosing decisions.
FDA to review Senseonics’ application for diabetes technology
Senseonics Holdings Inc., a diabetes medical technology company based in Germantown, will get some time before the Food and Drug Administration later this month.
Md. firm expands diabetes device deal with Swiss pharma giant
A Germantown-based medical technology company focusing on development of a device for people with diabetes recently expanded its distribution deal with a pharmaceutical giant. The exclusive deal between Senseonics Holdings […]
